Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 721-730 Newer>

Bio-IT World March 10, 2003 Michael Greeley	Too Much Informatics Did bioinformatics companies forget about the fundamental law of supply and demand?
CIO March 1, 2003 Scott Berinato	A Modest Prescription to Remedy Health Care's Ills Dr. Paul Ellwood, the inventor of the HMO and among the most important voices in American health care during the past three decades, believes there's only one way to fix the nation's health-care system: Embrace computers.
CRM February 2, 2003 David Myron	Vertical Focus: Pharmaceuticals Pharmaceutical companies are prolonging the good health of their customers -- and the CRM industry. Largely influenced by retiring Baby Boomers, lack of FDA-approved drugs in the pipeline, and direct selling campaigns, the industry is becoming more customer-focused.
CRM February 2003 David Myron	Support Gets a Face-Lift Allergan was able to automate the routing of 80 percent of all inbound, Web-generated emails, based on the business rules the company put in place.
American Family Physician February 15, 2003	Quantum Sufficit Coolibar's line of garments block the sun's harmful ultraviolet (UV) rays... Study of married couples shows that partners tend to share certain diseases... etc.
CIO February 15, 2003 Scott Berinato	All Systems Down A blow-by-blow record of one of the worst healthcare IT crises in history and what CareGroup CIO John Halamka learned from it.
Bio-IT World February 10, 2003 Mark D. Uehling	Decoding Estonia The former Soviet republic aims to use IT and culture to build a national gene database. It is modestly funded but is already being noticed by scientists and industry.
Bio-IT World February 10, 2003 Malorye Branca	The Art of the Deal Vertex Pharmaceuticals CEO Joshua Boger speaks about deal making and his company's success.
Bio-IT World February 10, 2003 Michael Swenson	HP's Shot at Dominance The new HP could become the leading systems provider for life science applications.
Bio-IT World February 10, 2003 Michael Greeley	The Upside of the Downturn Biotech entrepreneurs need to rethink how they raise capital and craft business model frameworks.
<Older 721-730 Newer> Return to current articles.